These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37522547)

  • 1. Adeno-Associated Virus-Mediated Gene Therapy.
    Zaman H; Khan A; Khan K; Toheed S; Abdullah M; Zeeshan HM; Hameed A; Umar M; Shahid M; Malik K; Afzal S
    Crit Rev Eukaryot Gene Expr; 2023; 33(6):87-100. PubMed ID: 37522547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
    Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
    Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vectors based on porcine adeno-associated viral serotypes transduce the murine and pig retina.
    Puppo A; Bello A; Manfredi A; Cesi G; Marrocco E; Della Corte M; Rossi S; Giunti M; Bacci ML; Simonelli F; Surace EM; Kobinger GP; Auricchio A
    PLoS One; 2013; 8(3):e59025. PubMed ID: 23520549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
    Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
    Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel AAV serotypes for improved ocular gene transfer.
    Lebherz C; Maguire A; Tang W; Bennett J; Wilson JM
    J Gene Med; 2008 Apr; 10(4):375-82. PubMed ID: 18278824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
    Grimm D; Kay MA
    Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.
    Allocca M; Doria M; Petrillo M; Colella P; Garcia-Hoyos M; Gibbs D; Kim SR; Maguire A; Rex TS; Di Vicino U; Cutillo L; Sparrow JR; Williams DS; Bennett J; Auricchio A
    J Clin Invest; 2008 May; 118(5):1955-64. PubMed ID: 18414684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
    Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
    Elife; 2021 Oct; 10():. PubMed ID: 34664552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.
    Carvalho LS; Xiao R; Wassmer SJ; Langsdorf A; Zinn E; Pacouret S; Shah S; Comander JI; Kim LA; Lim L; Vandenberghe LH
    Hum Gene Ther; 2018 Jul; 29(7):771-784. PubMed ID: 29325457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV
    Xiong W; Wu DM; Xue Y; Wang SK; Chung MJ; Ji X; Rana P; Zhao SR; Mai S; Cepko CL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5785-5794. PubMed ID: 30833387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SubILM Injection of AAV for Gene Delivery to the Retina.
    Gamlin PD; Alexander JJ; Boye SL; Witherspoon CD; Boye SE
    Methods Mol Biol; 2019; 1950():249-262. PubMed ID: 30783978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state of the art of adeno-associated virus-based vectors in gene therapy.
    Coura Rdos S; Nardi NB
    Virol J; 2007 Oct; 4():99. PubMed ID: 17939872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
    White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
    Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.